Evidence based healthcare for pharma products - Health Technology Assessment World Europe

Evidence based healthcare for pharma products

 

Download the brochure

Join our weekly newsletter:
 
 

Show overview

Health Technology Assessment World is the 6th annual policy forum for the industry where all the major HTA agencies across the world and leading pharmaceutical companies discuss the challenges in obtaining market access.

Francois Meyer, HAS, will discuss the important changes on the assessment in France, starting next October.
Alric Ruether, IQWIG, will update you on the situation in Germany and the art of evidence synthesis.
Merindert Boysen, NICE will provide an insight into technology appraisals at NICE in 2014.

Download the brochure for the full agenda and speaker list.

Download the brochure>
More about attending >

Top reasons to attend

At the conference, you will:

  • Discover how global healthcare reforms are impacting HTA and market access
  • Learn the latest HTA requirements from different HTA authorities across Europe
  • Understand developments in early dialogue / scientific advice for companies
  • Uncover the implications of value based pricing and how to plan for implementation
  • Master patient involvement in evidence development and HTA decision making

Download the brochure>
More about attending >

 

Download brochure

Download the brochure>
More about attending >

 

sponsors
Presentation Sponsor
Context Matters at Health Technology Assessment World Europe
Other
Executive Insight AG at Health Technology Assessment World Europe